MS drug found to benefit patients with more advanced disease – The Pharmaceutical Journal

Australia
  1. MS drug found to benefit patients with more advanced disease  The Pharmaceutical Journal
  2. Higher-dose ocrelizumab depletes more B cells but does not slow MS progression  News-Medical
  3. Ocrelizumab cuts disability progression in primary progressive MS trial  Medical Xpress

Leave a Comment

Your email address will not be published. Required fields are marked *